GlassScriptPhysician profile
Khoa D Tran
NPI 1346458908
$1,062.00
in general payments reported to CMS, 2019-2025
17 companies · $34.67 in 2025
The $34.67 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $178 · 2021: $136 · 2022: $12.31 · 2023: $234 · 2024: $245 · 2025: $34.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $294.75 | 2019-2024 | Invega Sustenna, Invega Trinza, Spravato |
| Sunovion Pharmaceuticals INC. | $122.93 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $97.94 | 2019-2023 | Rexulti |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $80.54 | 2021 | |
| Inari Medical, INC. | $59.86 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sun Pharmaceutical Industries INC. | $56.10 | 2023-2024 | Ilumya |
| Neurocrine Biosciences, INC. | $55.78 | 2021 | |
| Leo Pharma INC. | $55.40 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.67 | 2023 | |
| Abbvie INC. | $50.30 | 2023-2024 | Vraylar |
| Alkermes, INC. | $35.94 | 2019-2025 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $24.87 | 2023 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $18.50 | 2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $16.60 | 2025 | Austedo Xr |
| Corium, LLC | $15.93 | 2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $13.58 | 2023 | Perseris |
| Journey Medical Corporation | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khoa Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.